This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Freedman, M. L. Articles by Haiman, C. A. Search for Related Content PubMed PubMed Citation Articles by Freedman, M. L. Articles by Haiman, C. A.

A Haplotype-Based Case-Control Study of BRCA1 and Sporadic Breast Cancer Risk

¹ Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Departments of ² Medicine, ³ Molecular Biology, ⁴ Hematology/Oncology, and ⁵ Molecular Biology and Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts; ⁶ Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; and ⁷ Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii

Requests for reprints: Christopher A. Haiman, University of Southern California/Norris Comprehensive Cancer Center, Room 4441, 1441 Eastlake Avenue, Los Angeles, CA 90089-9175. Phone: 323-865-0429; Fax: 323-865-0127; E-mail: Haiman{at}usc.edu.

Rare, highly penetrant germ line mutations in BRCA1 strongly predispose women to a familial form of breast and ovarian cancer. Whether common variants (either coding or noncoding) at this locus contribute to the more common form of the disease is not yet known. We tested common variation across the BRCA1 locus in African American, Native Hawaiian, Japanese, Latino, and White women in the Multiethnic Cohort Study. Specifically, 28 single nucleotide polymorphisms (SNPs) spanning the BRCA1 gene were used to define patterns of common variation in these populations. The majority of SNPs were in strong linkage disequilibrium with one another, indicating that our survey captured most of the common inherited variation across this gene. Nine tagging SNPs, including five missense SNPs, were selected to predict the common BRCA1 variants and haplotypes among the non–African American groups (five additional SNPs were required for African Americans) and genotyped in a breast cancer case-control study nested in the Multiethnic Cohort Study (cases, n = 1,715; controls, n = 2,502). We found no evidence for significant associations between common variation in BRCA1 and risk of breast cancer. Given the large size of our study population and detailed analysis of the locus, this result indicates either that common variants in BRCA1 do not substantially influence sporadic breast cancer risk, or that unmeasured heterogeneity in the breast cancer phenotype or unmeasured interactions with genetic or environmental exposures obscure our ability to detect any influence that may be present.

This article has been cited by other articles:

				K Y-K Chan, W Liu, J-R Long, S-P Yip, S-Y Chan, X-O Shu, D T-T Chua, A N-Y Cheung, J C-Y Ching, H Cai, et al. Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women J. Med. Genet., January 1, 2009; 46(1): 32 - 39. [Abstract] [Full Text] [PDF]

				P. Chen, J. Liang, Z. Wang, X. Zhou, L. Chen, M. Li, D. Xie, Z. Hu, H. Shen, and H. Wang Association of Common PALB2 Polymorphisms with Breast Cancer Risk: A Case-Control Study Clin. Cancer Res., September 15, 2008; 14(18): 5931 - 5937. [Abstract] [Full Text] [PDF]

				C. A. Haiman, C. Hsu, P. I.W. de Bakker, M. Frasco, X. Sheng, D. Van Den Berg, J. T. Casagrande, L. N. Kolonel, L. Le Marchand, S. E. Hankinson, et al. Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations Hum. Mol. Genet., March 15, 2008; 17(6): 825 - 834. [Abstract] [Full Text] [PDF]

				J. A. Douglas, A. M. Levin, K. A. Zuhlke, A. M. Ray, G. R. Johnson, E. M. Lange, D. P. Wood, and K. A. Cooney Common Variation in the BRCA1 Gene and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1510 - 1516. [Abstract] [Full Text] [PDF]

				J. D. McKay, R. Kaaks, M. Johansson, C. Biessy, F. Wiklund, K. Balter, H.-O. Adami, C. Boillot, L. Gioia-Patricola, F. Canzian, et al. Haplotype-Based Analysis of Common Variation in the Growth Hormone Receptor Gene and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 169 - 173. [Abstract] [Full Text] [PDF]

				C. A. Haiman, D. O. Stram, I. Cheng, E. E. Giorgi, L. Pooler, K. Penney, L. Le Marchand, B. E. Henderson, and M. L. Freedman Common Genetic Variation at PTEN and Risk of Sporadic Breast and Prostate Cancer. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1021 - 1025. [Abstract] [Full Text] [PDF]